Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography

• Status: Unknown status
• Trial end date: 2005-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Morphine can induce constriction of sphincter of oddi and glucagon can facilitate bile secretion and dilatation of bile duct. We conduct this randomized double blinded study to evaluate the effect of enhancement in MRCP using intravenous morphine and glucagon.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: National Taiwan University Hospital
• Treatments: Glucagon; Glucagon-Like Peptide 1; Morphine

Criteria

Inclusion Criteria:

• normal volunteer

• living liver donor

Exclusion Criteria:

• COPD

• chronic liver disease

• hypersensitive to glucagon

• DM

• insulinoma

• glucagonoma

• pregnancy